Oscar Health, Inc. (NYSE:OSCR - Get Free Report)'s share price was up 6.7% during trading on Thursday . The stock traded as high as $14.32 and last traded at $14.30. Approximately 1,163,513 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 3,475,479 shares. The stock had previously closed at $13.40.
OSCR has been the topic of several recent analyst reports. Jefferies Financial Group began coverage on Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective on the stock. Piper Sandler reaffirmed an "overweight" rating and issued a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price on the stock. Finally, Bank of America lowered Oscar Health from a "neutral" rating to an "underperform" rating and reduced their target price for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $21.56.
Check Out Our Latest Report on Oscar Health
The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a fifty day simple moving average of $15.65 and a two-hundred day simple moving average of $17.28. The firm has a market capitalization of $3.50 billion, a P/E ratio of -236.13 and a beta of 1.63.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the previous year, the company posted ($0.29) EPS. The firm's revenue was up 68.3% compared to the same quarter last year. On average, equities research analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.
In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the transaction, the director now owns 89,512 shares of the company's stock, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $146,050.24. Following the completion of the sale, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. This represents a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 103,610 shares valued at $1,847,519. Insiders own 25.11% of the company's stock.
Several institutional investors have recently made changes to their positions in OSCR. Point72 Hong Kong Ltd purchased a new position in Oscar Health during the second quarter worth about $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health during the 2nd quarter valued at about $93,000. KBC Group NV grew its holdings in shares of Oscar Health by 41.2% during the third quarter. KBC Group NV now owns 4,552 shares of the company's stock worth $97,000 after purchasing an additional 1,328 shares in the last quarter. Amalgamated Bank increased its position in shares of Oscar Health by 27.7% in the second quarter. Amalgamated Bank now owns 6,727 shares of the company's stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Oscar Health in the third quarter worth approximately $142,000. Institutional investors own 75.70% of the company's stock.
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.